Rudy McCalebb

Rudy McCalebb has extensive experience in the pharmaceutical sales industry, particularly within oncology. Currently serving as a Senior Pharmaceutical Sales Representative and Senior Oncology Specialist at Helsinn Group since January 2018, McCalebb previously held a significant role in developing the Oncology Division at Daiichi Sankyo from October 2012, where responsibilities included educating healthcare providers across multiple Midwestern states. Prior to this, McCalebb worked for Quintiles as an Oncology Sales Representative, successfully launching a new compound for metastatic melanoma and exceeding sales objectives. Earlier positions included Midwest Sales Manager at Response Genetics and Associate Director at Imclone Systems, managing sales and developing diagnostic products. McCalebb's career commenced at Pfizer, where valuable expertise was gained in therapeutic specialties related to various cancers. McCalebb holds a BSBA in Business from Roosevelt University.